Media Affairs
@FDAMedia
Followers
16K
Following
21
Media
675
Statuses
4K
Official twitter account of FDA's Office of Media Affairs. Request for comment form: https://t.co/OSj4ocoElt
Silver Spring, MD
Joined May 2014
FDA Begins Real-Time Reporting of Adverse Event Data
fda.gov
The U.S. Food and Drug Administration (FDA) today began publishing adverse event data on a daily basis, giving the public faster access to information on serious medication errors and product quality...
2
2
2
HHS Allows FDA Emergency Use of Animal Drugs to Combat New World Screwworm, Protect U.S. Food Supply
fda.gov
The U.S. Department of Health and Human Services (HHS) today issued a declaration that allows the U.S. Food and Drug Administration (FDA) to issue Emergency Use Authorizations (EUAs) for animal drugs...
2
1
0
Blazing-fast image creation – using just your voice. Try Grok Imagine.
283
570
3K
FDA Approves First Immunotherapy for Recurrent Respiratory Papillomatosis
fda.gov
FDA approved Papzimeos, the first immunotherapy for use in adults with recurrent respiratory papillomatosis.
1
0
1
Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products
fda.gov
Statement from FDA Commissioner Marty Makary, M.D., M.P.H., on Florida Restriction of 7-OH Opioid Products
0
0
1
FDA Commissioner Makary, USDA Secretary Rollins Celebrate Proposed Modernization of Orange Juice Regulations to Benefit American Growers
fda.gov
U.S. FDA Commissioner Dr. Marty Makary, M.D., M.P.H., and U.S. Secretary of Agriculture Brooke L. Rollins this week announced plans to support American citrus growers and cut bureaucratic barriers by...
1
0
0
A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: Announcing Resolution of the IV Saline Solutions Shortage
fda.gov
A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: Announcing Resolution of the IV Saline Solutions Shortage
0
0
0
FDA Announces New FDA PreCheck Program to Boost U.S. Drug Manufacturing
fda.gov
The U.S. Food and Drug Administration today announced FDA PreCheck, a new program to strengthen the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the...
0
0
0
FDA Names Top HHS Lawyer as Chief Counsel
fda.gov
HHS, FDA today announced that Sean Keveney has been appointed Chief Counsel at the FDA.
1
1
0
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
fda.gov
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
0
2
0
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
fda.gov
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
2
2
1
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
fda.gov
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
1
1
1
FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys
fda.gov
The U.S. Food and Drug Administration is investigating the death of an 8-year-old boy who received Elevidys, a Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy.
0
3
0
HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods
fda.gov
HHS, FDA and USDA Address the Health Risks of Ultra-Processed Foods
1
1
1
HHS, FDA Praise Consumer Brands Association’s Vow to Remove Artificial Colors from America’s Food Supply
fda.gov
Today the leadership of the U.S. Department of Health and Human Services (HHS) praised the Consumer Brands Association for its pledge on behalf of the makers of the nation’s food and beverage...
0
0
0
Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research
fda.gov
The U.S. Food and Drug Administration today announced the appointment of George Francis Tidmarsh, M.D., Ph.D., as Director of the Center for Drug Evaluation and Research (CDER).
0
4
2
FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths
fda.gov
FDA is announcing today it has placed Elevidys and certain Sarepta investigational gene therapy clinical trials for limb girdle muscular dystrophy on clinical hold due to new safety concerns that the...
1
1
4
FDA to Revoke 52 Obsolete Standards of Identity for Food Products
fda.gov
FDA to Revoke 52 Obsolete Standards of Identity for Food Products
0
0
0
FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine
fda.gov
FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine
0
1
0
FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3
fda.gov
FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3
0
0
0
A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: 100 Days of Embracing Gold-Standard Science, Transparency and Common Sense
fda.gov
Embracing Gold-Standard Science, Transparency and Common Sense
0
1
0